The Dividend Yield as of September 2024 (TTM) for Syros Pharmaceuticals, Inc. (SYRS) is 0%

According to Syros Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Syros Pharmaceuticals, Inc. (SYRS) Historical Dividend Yield (quarterly & annually)

How has SYRS Dividend Yield performed in the past?

The mean historical Dividend Yield of Syros Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), SYRS's Dividend Yield was at its highest in in the December 2019 quarter at 0.05%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Syros Pharmaceuticals, Inc. (SYRS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Syros Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Syros Pharmaceuticals, Inc. (SYRS) Average Dividend Yield

How has SYRS Dividend Yield performed in the past?

The current Dividend Yield of Syros Pharmaceuticals, Inc. (SYRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Syros Pharmaceuticals, Inc. (SYRS) Dividend Yield vs. Peers

How is SYRS’s Dividend Yield compared to its peers?

Syros Pharmaceuticals, Inc.’s Dividend Yield is less than Surrozen, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Keros Therapeutics, Inc. (0%), less than Kezar Life Sciences, Inc. (0%), less than IDEAYA Biosciences, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Xencor, Inc. (0%), less than REGENXBIO Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Homology Medicines, Inc. (0%), less than Harpoon Therapeutics, Inc. (0%), less than Passage Bio, Inc. (0%), less than Pasithea Therapeutics Corp. (0%), less than Kronos Bio, Inc. (0%), less than Quoin Pharmaceuticals, Ltd. (0%), less than RenovoRx, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Coherus BioSciences, Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%),

Build a custom stock screener for Syros Pharmaceuticals, Inc. (SYRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syros Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Syros Pharmaceuticals, Inc. (SYRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Syros Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.